Retraction

Targeted Molecular Therapy in Melanoma

Paper Information

Record ID:
24314
Publication Date:
September 01, 2010
Retraction Date:
September 01, 2020 (5.2 years years ago)
Article Type:
Publisher:
Frontline Medical Communications
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Not indexed in PubMed

Retraction Details

Retraction Reason:

Duplication of/in Article

Nature of Retraction:

Retraction

Retraction Notice:
10.12788/j.sder.2020.001
Additional Notes:

Journal previously published by Elsevier;

Citations (48)

48
Total Citations
10
Post-Retraction
(20.8%)
38
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
6 After 2+ years
1262 Days since retraction (latest)
Malignant melanoma arising in mature teratoma with pugnacious spread: A case report
Sumedha Gupta, Shalu Solanki, Saritha Shamsunder et al. (5 authors)
Indian Journal of Obstetrics and Gynecology Research Open Access
Published: Feb 2024
1262 days after retraction
Data from Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence
Sam Garnett, Angeline de Bruyns, Veronique Provencher-Tom et al. (6 authors)
Unknown Journal Open Access
Published: Apr 2023
944 days after retraction
Data from Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence
Sam Garnett, Angeline de Bruyns, Veronique Provencher-Tom et al. (6 authors)
Unknown Journal Open Access
Published: Apr 2023
944 days after retraction
Data from MOB3A Bypasses BRAF and RAS Oncogene-Induced Senescence by Engaging the Hippo Pathway
Kendall Dutchak, Sam Garnett, Mary Nicoll et al. (5 authors)
Unknown Journal Open Access
Published: Apr 2023
944 days after retraction
BRAF V600E Immunohistochemistry Predicts Prognosis of Patients with Cutaneous Melanoma in Thai population
Jiraroch Meevassana, Kullawit Anothaisatapon, Surawish Subbalekha et al. (10 authors)
Plastic & Reconstructive Surgery Global Open Open Access
Published: Oct 2022
6 citations
760 days after retraction
Modified solid in oil nanodispersion containing vemurafenib-lipid complex-in vitro/in vivo study
Yasir Q. Аlmajidi, Nidhal K. Maraie, Ayad M.R. Raauf
F1000Research Open Access
Published: Sep 2022
3 citations
736 days after retraction
Modified solid in oil nanodispersion containing vemurafenib-lipid complex-in vitro/in vivo study
Yasir Q. Аlmajidi, Nidhal K. Maraie, Ayad M.R. Raauf
F1000Research Open Access
Published: Jul 2022
2 citations
694 days after retraction
MOB3A Bypasses BRAF and RAS Oncogene-Induced Senescence by Engaging the Hippo Pathway
Kendall Dutchak, Sam Garnett, Mary Nicoll et al. (5 authors)
Molecular Cancer Research Open Access
Published: Jan 2022
14 citations
505 days after retraction
Pulmonary Metastatic Melanoma: Current State of Diagnostic Imaging and Treatments
Kermit Zhang, Tomer Pelleg, Sabrina Campbell et al. (6 authors)
Melanoma Management Open Access
Published: Jul 2021
15 citations
310 days after retraction
Metabolic Regulator IAPP (Amylin) Is Required for BRAF and RAS Oncogene-Induced Senescence
Sam Garnett, Angeline de Bruyns, Veronique Provencher-Tom et al. (6 authors)
Molecular Cancer Research Open Access
Published: Jan 2021
5 citations
147 days after retraction
Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
Oindrila Bhattacharjee, Uttkarsh Ayyangar, Ambika S. Kurbet et al. (5 authors)
Frontiers in Cell and Developmental Biology Open Access
Published: May 2019
86 citations
483 days before retraction
Baicalein restrains proliferation, migration, and invasion of human malignant melanoma cells by down-regulating colon cancer associated transcript-1
Xiaoliang Yang, JinJie Jiang, Chunyan Zhang et al. (4 authors)
Brazilian Journal of Medical and Biological Research Open Access
Published: Jan 2019
15 citations
609 days before retraction
Discovery of two-level modular organization from matched genomic data via joint matrix tri-factorization
Jinyu Chen, Shihua Zhang
Nucleic Acids Research Open Access
Published: May 2018
31 citations
847 days before retraction
A rare melanoma feature with primary ovarian origin: a case report and the literature review
Paola Algeri, Rota Sonia Maria, Carlini Laura et al. (6 authors)
Obstetrics & Gynecology Science Open Access
Published: Jan 2018
6 citations
974 days before retraction
p53 loss does not permit escape from BrafV600E-induced senescence in a mouse model of lung cancer
Sam Garnett, Kendall Dutchak, Rosalie McDonough et al. (4 authors)
Oncogene Open Access
Published: Jul 2017
14 citations
1135 days before retraction
Point of care assessment of melanoma tumor signaling and metastatic burden from μNMR analysis of tumor fine needle aspirates and peripheral blood
Michael S. Gee, Arezou A. Ghazani, Rizwan Haq et al. (8 authors)
Nanomedicine Nanotechnology Biology and Medicine Open Access
Published: Dec 2016
10 citations
1353 days before retraction
Substituted 2-hydroxy-N-(arylalkyl)benzamide sensitizes cancer cells to metabolic stress by disrupting actin cytoskeleton and inhibiting autophagic flux
Gabriela Páchniková, Stjepan Uldrijan, Aleš Imramovský et al. (5 authors)
Toxicology in Vitro
Published: Sep 2016
3 citations
1454 days before retraction
Micellar electrokinetic chromatographic method for the dabrafenib determination in biological samples
Juana Rodrı́guez, Gregorio Castañeda, Lorena Muñoz et al. (5 authors)
Electrophoresis
Published: Feb 2016
6 citations
1659 days before retraction
Integrative analysis for identifying joint modular patterns of gene-expression and drug-response data
Jinyu Chen, Shihua Zhang
Bioinformatics Open Access
Published: Feb 2016
78 citations
1674 days before retraction
Nanotechnology-based strategies for combating toxicity and resistance in melanoma therapy
Adam K. Brys, Raghavendra Gowda, Daniel B. Loriaux et al. (5 authors)
Biotechnology Advances
Published: Jan 2016
50 citations
1678 days before retraction
Beyond Red Hair and Sunburns: Uncovering the Molecular Mechanisms of MC1R Signaling and Repair of UV-Induced DNA Damage
Pamela B. Cassidy, Zalfa Abdel‐Malek, Sancy A. Leachman
Journal of Investigative Dermatology Open Access
Published: Nov 2015
15 citations
1751 days before retraction
Personalized Therapy of Cancer
Kewal K. Jain
Springer eBooks
Published: Jan 2015
1 citation
2070 days before retraction
Efeito do resveratrol e do 2-Metoxiestradiol em linhagens de melanoma humano em modelos de monocamada e de pele reconstituída
Renato Ramos Massaro
Unknown Journal Open Access
Published: Dec 2014
2083 days before retraction
Therapy of Melanoma
A. Neil Crowson, Cynthia M. Magro, Martín C. Mihm
Unknown Journal
Published: Jan 2014
2419 days before retraction
Genome-wide profiling of copy number alterations in cancer: focus on melanoma
Luigi Pasini
Biomedical Reviews
Published: Dec 2013
2 citations
2436 days before retraction
Identifying Strategies to Optimize Care With Oral Cancer Therapy
Peg Esper
Clinical journal of oncology nursing
Published: Nov 2013
12 citations
2471 days before retraction
Personalized Cancer Therapy
Kewal K. Jain
Springer eBooks
Published: Oct 2013
1 citation
2499 days before retraction
Genotipificación del melanoma en Colombia.
Hernán Carranza, Pilar Archila, Carlos Vargas et al. (25 authors)
Revista Colombiana de Hematología y Oncología Open Access
Published: Oct 2013
4 citations
2527 days before retraction
Molecular Pathology and Diagnostics of Cutaneous Malignancy
Sudeep Gaudi, Patricia Moody McNab, Timothy McCardle et al. (4 authors)
Springer eBooks
Published: Sep 2013
2552 days before retraction
Antitumor Activity of Tumor-Targeted RNA Replicase-Based Plasmid That Expresses Interleukin-2 in a Murine Melanoma Model
B. Leticia Rodriguez, Jorge Blando, Dharmika S.P. Lansakara-P et al. (6 authors)
Molecular Pharmaceutics Open Access
Published: May 2013
14 citations
2676 days before retraction
Liquid chromatography–tandem mass spectrometric assay for the mutated BRAF inhibitor dabrafenib in mouse plasma
Rolf W. Sparidans, Selvi Durmuş, Alfred H. Schinkel et al. (5 authors)
Journal of Chromatography B
Published: Feb 2013
14 citations
2743 days before retraction
Vemurafenib Induces Senescence Features in Melanoma Cells
Sebastian Haferkamp, Andreas Borst, Christian Adam et al. (9 authors)
Journal of Investigative Dermatology Open Access
Published: Jan 2013
106 citations
2786 days before retraction
New Therapeutic Targets in Melanoma
Manuel Martín González, Anabel Sorolla, Andrée Yeramian
Actas Dermo-Sifiliográficas Open Access
Published: Sep 2012
15 citations
2922 days before retraction
Management of Pigmented Conjunctival Lesions
Patrick Oellers, Carol L. Karp
The Ocular Surface
Published: Aug 2012
70 citations
2943 days before retraction
Conformation-Specific Effects of Raf Kinase Inhibitors
Xiaolun Wang, Joseph Kim
Journal of Medicinal Chemistry
Published: Jul 2012
47 citations
2967 days before retraction
Circumventing Melanoma Chemoresistance by Targeting DNA Repair
Simone Mocellin, Loris Bertazza, Clara Benna et al. (4 authors)
Current Medicinal Chemistry
Published: Jul 2012
10 citations
2984 days before retraction
Vemurafenib in Patients With BRAF V600E Mutation–Positive Advanced Melanoma
Marcus Ravnan, Mazen S. Matalka
Clinical Therapeutics
Published: Jun 2012
84 citations
2988 days before retraction
Upcoming strategies for the treatment of metastatic melanoma
Francesco Spagnolo, Paola Queirolo
Archives of Dermatological Research
Published: Feb 2012
50 citations
3120 days before retraction
Nuevas dianas terapéuticas en el melanoma
Manuel Martín González, Anabel Sorolla, Andrée Yeramian
Actas Dermo-Sifiliográficas
Published: Jan 2012
12 citations
3142 days before retraction
Ras/Raf and Their Influence in Glycolysis in Colon Cancer
Fred Bunz, Nickolas Papadopoulos
Springer eBooks
Published: Jan 2012
2 citations
3166 days before retraction
Paper citing Targeted Molecular Therapy in Melanoma...
Unknown Authors
Unknown Journal
Published: Dec 2011
3170 days before retraction
Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review
F. Durbec, Ludovic Martin, Christian Derancourt et al. (4 authors)
British Journal of Dermatology
Published: Dec 2011
132 citations
3181 days before retraction
Trp2 Peptide Vaccine Adjuvanted with (<i>R</i>)-DOTAP Inhibits Tumor Growth in an Advanced Melanoma Model
Elizabeth A. Vasievich, Srinivas Ramishetti, Yuan Zhang et al. (4 authors)
Molecular Pharmaceutics Open Access
Published: Dec 2011
51 citations
3193 days before retraction
Melanoma Cell Signalling: Looking Beyond RAS-RAF-MEK
Visalini Muthusamy, J. Terrence
InTech eBooks Open Access
Published: Nov 2011
1 citation
3214 days before retraction
NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway
Yee Mon Thu, Yan Ru Su, Jinming Yang et al. (9 authors)
Oncogene Open Access
Published: Oct 2011
44 citations
3256 days before retraction
Molecular Bases of Cutaneous and Uveal Melanomas
Sudeep Gaudi, Jane L. Messina
Pathology Research International Open Access
Published: Aug 2011
26 citations
3302 days before retraction
Diagnostic challenge for ovarian malignant melanoma in premenopausal women: Primary or metastatic?
Yassir Sbitti, Zouhour Fadoukhair, Habiba Kadiri et al. (10 authors)
World Journal of Surgical Oncology Open Access
Published: Jun 2011
20 citations
3364 days before retraction
Nuclear Medicine in Early-Stage Melanoma: Sentinel Node Biopsy—FDG-PET/CT
Elif Hindié, Farid Sarandi, S. Banayan et al. (9 authors)
PET Clinics
Published: Jan 2011
6 citations
3531 days before retraction
Quick Stats
Total Citations: 48
Years Since Retraction: 5.2 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Update on the genetics of androgenetic alopecia, female pat…
Seminars in Cutaneous Medicine and Surgery • 8 citations